Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women
- 86 Downloads
To assess postmenopausal breast cancer risk in relation to particular patterns of oral contraceptive (OC) use according to hormone replacement therapy (HRT) exposure.
Time-dependent Cox regression models were used to analyse information on postmenopausal women from a large-scale French cohort. Among a total of 68,670 women born between 1925 and 1950, 1405 primary invasive postmenopausal breast cancer cases were identified from 1992 to 2000.
A non-significant decrease in risk of around 10% was associated with ever OC use as compared to never OC use in postmenopausal women. No significant interaction was found between OC and HRT use on postmenopausal breast cancer risk. Breast cancer risk decreased significantly with increasing time since first OC use (test for trend: p=0.01); this was consistent after adjustment for duration of use or for time since last use.
No increase in breast cancer risk was associated with previous OC exposure among postmenopausal women, probably because the induction window had closed. Some women may develop breast cancer soon after exposure to OCs, leading to a deficit of cases of older women. Further investigation is therefore required to identify young women at high risk.
Keywordsbreast cancer postmenopausal women oral contraceptives patterns of use hormone replacement therapy.
Unable to display preview. Download preview PDF.
- 1.Collaborative Group on Hormonal Factors in Breast Cancer1996Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studiesLancet34717131727Google Scholar
- 8.Million Women Study Collaborators2003Breast cancer and hormone-replacement therapy in the Million Women StudyLancet362419427Google Scholar
- 9.Writing Group for the Women’s Health Initiative Investigators2002Risk and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women’s Health Initiative randomized controlled trialJAMA288321333Google Scholar
- 10.Collaborative Group on Hormonal Factors in Breast Cancer1997Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancerLancet35010471059Google Scholar
- 12.Fournier A, Berrino F, Riboli E, Avenel V, Clavel-Chapelon F (2004) Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer (in press).Google Scholar
- 16.Collaborative Group on Hormonal Factors in Breast Cancer1996Breast cancer and hormonal contraceptives: Further resultsContraception541S106SGoogle Scholar
- 25.Greenland, S 1998Applications of stratified analysis methodsRothman, KJGreenland, S eds. Modern Epidemiology2Lippincott-RavenPhiladelphia297300Google Scholar